title: A Decision Aid to Support Informed Choices for Patients Recently Diagnosed With Prostate Cancer: A Randomized Controlled Trial.
abstract: BACKGROUND
  Decision aids provide balanced information about the benefits and risks of treatment options and improve the match between patient preferences and the treatment received.
  
  
  OBJECTIVE
  To assess the impact of a decision aid regarding the treatment options for patients with localized prostate cancer.
  
  
  METHODS
  A 2-arm randomized controlled trial was used to compare booklet patient decision aid (intervention group n = 61) with standard information for localized prostate cancer (control group n = 61). The study was conducted at 3 hospitals between 2011 and 2013. The main outcome measures were knowledge, decisional conflict, satisfaction with the decision-making process, and coping.
  
  
  RESULTS
  The respective mean Decisional Conflict Scale scores before and after the intervention were 53.0 ± 16.9 and 31.2 ± 10.2 in the intervention group and 49.1 ± 13.7 and 51.7 ± 13.3 in the control group (P < .001). Mean Knowledge scores were 38.6 ± 16.5 and 75.7 ± 19.0 in the intervention group and 42.0 ± 17.6 and 49.9 ± 16.0 in the control group (P < .001). Mean Satisfaction With Decision Scale scores were 81.1 ± 8.92 and 95.7 ± 6.89 in the intervention group and 82.5 ± 12.0 and 79.3 ± 10.3 in the control group (P < .001).
  
  
  CONCLUSIONS
  Decision aid not only improved patient knowledge about localized prostate cancer and its treatment and their satisfaction with decision making but also decreased their decisional conflict.
  
  
  CONCLUSIONS
  Decision aid represents a rather innovative approach for a health insurance fund to develop and offer this format of information and decision support. This opens a new field of study for nurses to empower patients in the decision-making process and develop new roles in this area.
authors.affiliation: Author Affiliations: School of Health Science-TecnoCampus, Department of Nursing, University Pompeu Fabra, Mataró (Ms Chabrera); Departments of Oncology (Ms Chabrera and Dr Font) and Radiation Oncology (Dr Caro), Catalan Institute of Oncology, Badalona; Hospital Clinic, Barcelona (Dr Zabalegui); Oncology Institute of Vallés, Terrassa (Dr Bonet); Department of Urology, University Hospital Germans Trias i Pujol, Badalona (Dr Areal); and Center for Research in Environmental Epidemiology-CREAL, Barcelona (Dr González), Spain.
authors.forename: Carolina
authors.initials: C
authors.lastname: Chabrera
authors.forename: Adelaida
authors.initials: A
authors.lastname: Zabalegui
authors.forename: Marta
authors.initials: M
authors.lastname: Bonet
authors.forename: Mónica
authors.initials: M
authors.lastname: Caro
authors.forename: Joan
authors.initials: J
authors.lastname: Areal
authors.forename: Juan R
authors.initials: JR
authors.lastname: González
authors.forename: Albert
authors.initials: A
authors.lastname: Font
mesh_terms: D000367:Age Factors; D000368:Aged; D003657:Decision Making; D003661:Decision Support Techniques; D005500:Follow-Up Studies; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D010358:Patient Participation / Q000706:statistics & numerical data; D057240:Patient Preference; D011446:Prospective Studies; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D018570:Risk Assessment; D013997:Time Factors